Saba Al-Hashimi is an Ophthalmology physician affiliated with University of California, Los Angeles. OpenAlex indexes 23 publications with 331 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Stein Plz
Suite 302
Los Angeles, CA 900950001
Telephone
310-825-5501Provider last certified this registry record 23 Jan 2025.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20251 payment
- Carl Zeiss Meditec USA, Inc.Program year20251 payment
- Dompe US, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
64.9%Corticosteroid39%Prednisolone Acetate94%Fluorometholone6%Part D≥220 patientsCorticosteroids, plain5.8%Loteprednol Etabonate88%Difluprednate12%Part D<11 patients+ 7 more classes in this area
Anti-infectives
20.8%Fluoroquinolone Antibacterial15.5%Moxifloxacin100%Part D≥128 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor2.5%Valacyclovir100%Part D≥13 patients+ 3 more classes in this area
Cancer & immunology
10.4%Calcineurin inhibitor10.4%Cyclosporine39%Restasis35%Cequa19%Vevye8%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prospective, Randomized Trial Comparing Simulator-based versus Traditional Teaching of Direct Ophthalmoscopy for Medical Students
American Journal of Ophthalmology
2021 - Complications of Cosmetic Artificial Iris Implantation and Post Explantation Outcomes
American Journal of Ophthalmology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”